![]() Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | |
Founding Date | Founding Date 2020 | Founding Date 1980 | Founding Date 1923 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more |
Employees | Employees 38,0003% increase | Employees 25,200 | Employees 14,754 |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 170.4 b | Valuation ($) 20.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $12b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $24.7b (FY, 2025) | Gross profit ¥2t (FY, 2026) |
Net income | Net income ($3.5b) (FY, 2025) | Net income $7.7b (FY, 2025) | Net income ¥291.6b (FY, 2026) |
Operating ⚠ | |||
Countries | Countries 165 (Q1, 2023) | Countries 100 (FY, 2020) | Countries N/A |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company